Long term follow-up of ewing's sarcoma patients treated with combined modality therapy
β Scribed by T.J. Kinsella; J. Miser; B. Walled; D. Venzon; E. Glatstein; L. Weaver; M. Horowitz
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 132 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract One hundred and twentyβone consecutive patients with monostotic Ewing's sarcoma (ES) were treated according to three consecutive combined modality programs from 1974 to 1986. Their 3βyear progression free survival (PFS) rate from diagnosis of 59% was identical to the event free survival
While the proportion of patients with Ewing's sarcoma attaining and maintaining long-term remission has markedly improved, a proportion of patients suffer relapse of the tumor. In our experience relapses may occur late in the course of the disease, approximately 20% of those at risk beyond 5 years h